chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Difficulty in recovering after going up stairs; pain in the back and chest; started feeling pain on the back; Mild pain on the R arm of injection; Feels weak and fatigated; Bone pain; Cold sweating; Pain when trying to open the eyes; Feels weak / felt weak for three days.; This spontaneous case was reported by a non-health professional and describes the occurrence of PAIN (Difficulty in recovering after going up stairs), NON-CARDIAC CHEST PAIN (pain in the back and chest), BACK PAIN (started feeling pain on the back), BONE PAIN (Bone pain) and COLD SWEAT (Cold sweating) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027A21A and 042620A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Open heart surgery (Two open heart surgery). Concomitant products included WARFARIN for Heart enlarged, VITAMINS NOS for an unknown indication.   On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 21-Jun-2021, the patient experienced BONE PAIN (Bone pain), COLD SWEAT (Cold sweating), EYE PAIN (Pain when trying to open the eyes) and ASTHENIA (Feels weak / felt weak for three days.). On an unknown date, the patient experienced PAIN (Difficulty in recovering after going up stairs), NON-CARDIAC CHEST PAIN (pain in the back and chest), BACK PAIN (started feeling pain on the back), VACCINATION SITE PAIN (Mild pain on the R arm of injection) and FATIGUE (Feels weak and fatigated). At the time of the report, PAIN (Difficulty in recovering after going up stairs), NON-CARDIAC CHEST PAIN (pain in the back and chest), BACK PAIN (started feeling pain on the back), BONE PAIN (Bone pain), COLD SWEAT (Cold sweating), EYE PAIN (Pain when trying to open the eyes), ASTHENIA (Feels weak / felt weak for three days.), VACCINATION SITE PAIN (Mild pain on the R arm of injection) and FATIGUE (Feels weak and fatigated) outcome was unknown.            No treatment medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 28-Jun-2021: Follow up received on 28-JUN-2021 contained significant information Event Felt weak for 3 days , Bone pain, Cold sweating, Pain when trying to opening eye (Unknown) was updated On 28-Jun-2021: Follow up received on 29-JUN-2021 contained No New Information Non significant information
I had trouble breathing and went to the ER with chest pains. They did a Chest X-ray with contrast. They found I had a round glass opacity and a possible mass on my left lung. I went back for a recheck in three months. The mass has gone but the round glass opacity is still there. My doctors have determined the vaccine caused this issue. I am know using a daily inhaler and I have an emergency inhaler. I cannot walk up a flight of stairs or walk through a store without getting winded. If my life were in danger and I had to run, I could not do it.
This non-serious initial spontaneous case, was received on 01-Nov-2017, from a physician, concerning an adult male patient of unspecified age. This refers 03 of 84 patients. On an unspecified date in Oct-2017 (between 25-Oct-17 to 27-Oct-17), the patient was administered with AFLURIA (TIV) Thiomersal (batch number: 14649211A, dose, route of administration, anatomical location and expiry date: not reported). It was reported that, the vaccine was stored in a cooler with ice packs for 6 days and had reached unknown temperature during transport instead of storing at 36-degree F and 46-degree F (2-degree C and 8-degree C). And the same was administered to the patient. The reporter stated that the temperature was not monitored on 24-Oct-2017 (could have been between 2-8C, but not certain) and there were no reports of adverse effect after vaccination. The vaccine had been discarded. Follow up received on 09-Nov-2017 from a physician: Added event (no adverse effect) and reporter's comment. Amended narrative accordingly.
left arm swelling at site approximately egg size lasted for 3 days, left arm numbness and discomfort lasted currently described as "bone deep pain."  Joint swelling and pain at knees, ankles and hips and headache.
scattered maculopapular rash over body appearing beginning 8 days p/vax;
07/12/2010 Mild. Other. Pt had 2nd VARIVAX. No fever noted, pt had swelling and redness at the injection site up to.
Patient stated that she was tingly in her right arm 15 minutes after administration of vaccine. This progressed to itching all over.  Patient was very anxious stating that this occurred with the varicella vaccine as well  and that "something always happens to me." Patient reported no allergies and no difficulty breathing, dizziness, tingling of the mouth or face, or numbness. 50mg of Benadryl was administered and patient was monitored for an additional 30 minutes. Patient consumed snacks and drink and felt ok to leave at 0935. Patient was educated by RN about serious adverse reactions to monitor for and to call 911 immediately if patient experienced these.
bumps near hairline; nerve pain; shingles; sharp pains in the head; This spontaneous case was reported by a consumer and describes the occurrence of FURUNCLE (bumps near hairline), NEURALGIA (nerve pain), HERPES ZOSTER (shingles) and HEADACHE (sharp pains in the head) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037B21A and 037B21A) for COVID-19 vaccination.     Previously administered products included for an unreported indication: SHINGRIX (Patient had a shingles shot 2 years ago). Concomitant products included AMOXICILLIN TRIHYDRATE, CLARITHROMYCIN, ESOMEPRAZOLE MAGNESIUM (NEXIUM 1-2-3), HYDROCHLOROTHIAZIDE, ATORVASTATIN, METOPROLOL and ADALIMUMAB (HUMIRA) for an unknown indication.   On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 11-Apr-2021, the patient experienced FURUNCLE (bumps near hairline), NEURALGIA (nerve pain), HERPES ZOSTER (shingles) and HEADACHE (sharp pains in the head). At the time of the report, FURUNCLE (bumps near hairline), NEURALGIA (nerve pain), HERPES ZOSTER (shingles) and HEADACHE (sharp pains in the head) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient had a shingles shot 2 years ago
Began on evening of 6/2/18 with two hours of vomiting for a total of three times. On Wednesday evening (6/6/18) through Thursday morning (6/7/18) four episodes of tan, foamy diarrhea and enlarged lymph nodes behind both ears.
Pt stated she broke out in rash on right side of chest wall 1 day after receiving Shingrix. Pt was prescribed Valtrex, Tylenol #3, and Gabapentin
Presented to ER on 12/27/21 with a 5 day history of cough, subjective fevers/chills, diarrhea, body aches, loss of sense of taste and smell, and shortness of breath. Patient received the Johnson and Johnson COVID vaccine on June 15, 2021.  CXR appears to demonstrate rather diffuse atypical pneumonia. Currently on RA however is tachycardic and tachypnic in between sentences.  Receiving IV dexamethasone and albuterol in the ED.  Was admitted for further management following completion of ED workup. COVID positive on 12/23/21. Started on Decadron.  Was monitored overnight.  Her oxygen saturation remained stable.  Shortness of breath did improve.  Also remained afebrile overnight.  She was stable for discharge.  Was discharged on a course of Decadron as well as azithromycin.  Discharged on 12/28/21
light headed and dizzy, mild; This is a spontaneous report from a contactable consumer (patient). A 42-year-old female patient received first single dose of BNT162B2 (Pfizer, solution for injection, lot number: EL3247, exp date not reported), via an unspecified route of administration (vaccine location: right arm) on 11Feb2021 10:30 to 11Feb2021 10:30 at SINGLE DOSE for COVID-19 immunisation. Facility where the most recent COVID-19 vaccine was administered: Workplace clinic. The patient had no relevant medical history. The patient was not pregnant at the time of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Patient had no allergies to medications, food, or other products. There was no other medication received within 2 weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. There was no other medication received within 2 weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced light headed and dizzy, mild; lasted day of injection on 11Feb2021 16:00. The event was considered as non-serious by the reporter. No treatment received for the adverse event. Since the vaccination, the patient had not been tested for COVID-19. The patient recovered from the event on an unspecified date in Feb2021.
Information has been received from a Registered nurse, concerning a 67 year old female with no known drug allergies, who on 16-SEP-2009 was vaccinated with a 0.5 mL dose of PNEUMOVAX 23 (lot# 662842/1296X) intramuscularly into the left arm. Concomitant therapy included a dose of influenza virus vaccine (unspecified). On the same day, the patient experienced fingers tingling, on the left arm and then pain that went up to elbow and moved up to the whole arm. The patient's pain scale was 10 out of 10. The patient was unable to use the left arm. They also had nausea. The patient went to an unspecified walk in clinic in the morning. The patient was given IV REGLAN, DILAUDID and a 3rd unspecified medication that was considered by the nurse to be intervention to prevent serious criteria. At the time of reporting the patient had not recovered. Fingers tingling, pain that went up to the elbow and nausea were considered to be disabling by the reporting nurse because the patient could not move her arm. Upon internal review the fingers tingling, pain that went up to the elbow and nausea were determined to be other important medical events. This is one of several reports from the same source. Additional information has been requested.
Injection site sorenes, pain, tenderness,. Fatigue, headache, joint pain, chills, nausea, muscle pain, Laborous breathing  Sunday 3/29-3/30 due to no bowl movement.  Also experienced extreme dizziness and weakness which resulted Sunday -Thursday (3/28 - 3/31)  Went to the ER on  3/31/21 with severe cramping, nausua, fatigue, chills and headache.  Unable to drive myself and get out of bed and walk.   Elevated heartbeat Sunday - Tuesday (3/28-3/30). First bowl movement was after the shot for was day 7 after the shot. with medical assistance.
Pt given MMR vax w/in 5min edematous reddened area (50mm x 40mm) noted at site;
Varicella disease on back of neck and behind ears, less than 50 pox.
My sister became SOB within weeks of receiving the Vaccine She sought medical treatment but they treated her Asthma with Prednisone. She called me at 8pm on 12/8 and was complaining of leg pain and SOB . She worked at a hospital so was going to go to the ER when she got there. They had to pull over on the way and call an ambulance. She never made it. The autopsy showed large Embolism in her Calf that she was C/O of pain and multiple lung clots. The health dept. didn't offer her the Vsafe testing to check on her They didn't explain anything to her. and She should have never received the Johnson and Johnson because the benefit did NOT out weight the risk. She was going to make more money an hour which is the only reason she agreed to the Vaccine.
This spontaneous report was received from a pharmacist concerning a patient of unknown age and gender. There was no information about the patient's concurrent conditions, medical history or concomitant medication. In September 2016 the patient was vaccinated with GARDASIL for prophylaxis (dose, route of administration, lot number and expiration date were not reported). The patient later received GARDASIL 9 intramuscularly (lot number L014198, expiration date 05-SEP-2017) as the second dose of the HPV series, in December 2016. No adverse effects were reported. Additional information has been requested.
Swelling, redness, and warmth around the site of vaccine administration within the first 24hrs. Then developed progressive worsening of above symptoms over the next day. Rash developed on the skin surrounding administration site over the next few days.
Information has been received from a 64 year old nurse with blood pressure high reporting about herself who on 12-MAR-2012, was vaccinated with a dose of ZOSTAVAX (Merck), (dose, route and Lot # not reported). Concomitant therapy included LIPITOR and "bp medicine" (manufacturer unknown). On 13-MAR-2012, the patient experienced red, hot, rash on her arm size of a tennis ball after vaccination. The patient reported that the rash went away over time but now she had a black and blue mark on her arm. The patient sought unspecified medical attention. BENADRYL was given for adverse event treatment. At the time of the report the patient's status was not recovered. Follow up information has been received from a physician reporting about 64 year old female patient with history of chickenpox of age 10 and none known drug allergies who was vaccinated with a dose of ZOSTAVAX (Merck), (dose, route and Lot # not reported). Concomitant therapy included LIPITOR, ZOLOFT, ENDOPRIL and TRAVATAN. On 14-MAR-2012 the patient developed 3 cm round, red, warm, raised lesion on left arm reported also as swollen hives type lesion (rash type) on left arm just above elbow. Outcome was not reported. Follow up information was received (28-MAR-2013): Updated the medical history, administrator information and narrative. Changed the onset date of red, hot, rash on her arm into 12-MAR-2012. The patient was treated with Augmentin 500/125 mg, po, TID x 7 days and vesolver. No further information is available.
Fever, sever chills, body aches, unable to get out of bed x 24 hours
13AUG95 site red, swollen, warm, small bruise @ distal edge; swelling @ greatest bigger than golf ball; cold compress w/o relief; 17AUG95 warm compress w/relief
Quick fever up to 103.3 degrees F, congestion, cough soreness in throat;
This spontaneous report was received from a nurse and refers to multiple unspecified patients of unknown age and gender. The patients' pertinent medical history, drug reactions or allergies and concomitant therapies were not reported. On unknown dates, the patients were vaccinated with improperly stores doses of PNEUMOVAX 23 (exact dose, route, lot # and expiration date were not reported). The administered doses experienced a temperature excursion of 34.7 degrees Fahrenheit for 2 hours. There was no previous temperature excursion. The stored vaccines were back in proper temperature range. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Client received CanSino COVID vaccine with no reaction. CanSino vaccine not approved by the World Health Organization. Janssen given as an alternative on 9.15.21.
A very painful headache all over head, chills, sweat, slight nausea. Lasted over 24 hours, could not function normally.
7 days post-vaccination (1st shot), my vaccinated arm had large hard swelling which was hot, red and itchy.  Swelling went down after 2 days, red rash and itching went away after a week.
Left upper arm edema and erythema warm to touch. Tender to touch and pruritic.
Bilateral thigh erythema and edema. Dx: allergic reaction; Rx: steroids x 3 days and BENADRYL PRN.
wasn't up to doing anything; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (wasn't up to doing anything) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ASTHENIA (wasn't up to doing anything). At the time of the report, ASTHENIA (wasn't up to doing anything) outcome was unknown.            Action taken with mRNA-1273 in response to the events was not applicable
Dizzy like she just got off of a roller coaster; Arm is a little sore; she thinks she is having a panic attack; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizzy like she just got off of a roller coaster), INJECTION SITE PAIN (Arm is a little sore) and PANIC ATTACK (she thinks she is having a panic attack) in a 29-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 13-Jan-2021 at 12:30 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jan-2021, the patient experienced DIZZINESS (Dizzy like she just got off of a roller coaster), INJECTION SITE PAIN (Arm is a little sore) and PANIC ATTACK (she thinks she is having a panic attack). At the time of the report, DIZZINESS (Dizzy like she just got off of a roller coaster), INJECTION SITE PAIN (Arm is a little sore) and PANIC ATTACK (she thinks she is having a panic attack) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medication was reported to be taken as TYLENOL. Concomitant product use was not provided by the reporter; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
"light bowels, almost watery" She says it's like diarrhea.; "stomach feels crampy"; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 62 year-old female patient received bnt162b2 (BNT162B2), administration date 02Apr2021 (Batch/Lot number: unknown) at the age of 62 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DIARRHOEA (non-serious), outcome "unknown", described as ""light bowels, almost watery" She says it's like diarrhea."; ABDOMINAL PAIN (non-serious), outcome "unknown", described as ""stomach feels crampy"".  Additional Information: For the past week, she's been experiencing "light bowels, almost watery". She says it's like diarrhea. It's now been almost 1 week. She also mentioned her "stomach feels crampy".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Patient had some arm pain the day after vaccines on 8/16/17, but was told that that was a normal reaction. On 9/5/17, patient came into pharmacy complaining of pain continuing in arm/shoulder area at a scale of 5-8 out of 10 for 90-95% of the time. She also complained of muscle/arm weakness, sometimes so bad that it is difficult to dress herself and has to physically pick up the arm with her other hand.
No additional AE PQC reported; temperature excursion PROQUAD were administered to 5 patients; This spontaneous report has been received from a physician assistant concerning to a 13-months-old child patient of unknown gender.  The patient's concurrent conditions, medical history and concomitant medications were not provided.  On 11-AUG-2021, the patient was vaccinated with an improperly stored dose of Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) (route of administration, dose number and dose were not provided) (lot#: T034613, expiration date: 10-APR-2022) (product storage error) as prophylaxis. The total temperature excursion was above -15 degree Celsius (-5 degree Celsius) for a total time frame of 15 minutes. There were no previous temperature excursions. No additional adverse events were reported.  This case is one of six cases received from the same reporter.; Sender's Comments:  US-009507513-2108USA004895: US-009507513-2108USA004878: US-009507513-2108USA004893: US-009507513-2108USA004896: US-009507513-2108USA004892:
Immediate pain after injection. The following mortars became swollen from shoulder to elbow with red patch on bicep. Severe pain, limited movement of shoulder and wrist. Discomfort led to neck. No improvement by 3/1/21. Morning of 3/2 was somewhat better but pain returned by afternoon with itching of bicep area.
Fever, Nausea, Muscle Aches, Extreme Fatigue, Swollen Lymph Nodes, Headache
About one week  after receiving the vaccine (2/1/2021) I developed itching  and a large  red circular swelling at the site of the vaccine.  The spot was sore and warm to the touch and appeared to have small white spots at the swelling.  As of today (2/4/2021) the area is still red and itchy but is not as warm as it has been for the past few days.
Itching at vaccine site, small vesicle noted.  Area covered with semipermeable dressing.  Pt. had taken Prednisone 4 days prior to this reaction.
I had my second shot on April 30th, and on the morning of May 5th I experienced pain in my chest, irregular heart rhythms, and a general feeling of not being able to catch my breath.  For a short time I felt light-headedness and a tingling in my feet/lower legs, and told my husband I might pass out. I was in the car as a passenger. So I went to an urgent care in that area. By the time I saw a DR the symptoms were abating and the ekg did not show any issues.
Headaches started 2 or so weeks after second dose. Daily headaches with no other cause, no changes in diet, medication, activity, sleep, injury, posture, etc.  Pain present every day since onset.  Helped by 600mg of ibuprofen every 5-6 hours, pain returns immediately if next dose not taken.
Patient reported to pharmacy on 1/18/20 that right arm was hurting in shoulder and around to the back of the shoulder since getting vaccine
Patient has flu-like symptoms with myalgia, fatigue, chills, chest tightness, SOB x 1 week. Patient is getting better after natural treatments.
Patient experienced shortness of breath beginning one day after her MMR vaccine. Patient was hospitalized due to sypmtoms. 12/2/08-records received for DOS 11/21/08-ED visit for C/O palpitations, numbness in hands sense of impending doom. DX: Panic disorder without agoraphobia. Observed and discharged home.
States 2 hours after received FLUCELVAX at work developed hives and treated self with 25 mg BENADRYL and ZYRTEC with some relief. Four hours later developed "rebound" reaction with generalized urticaria -> itchy throat, treated with 50 mg BENADRYL and after consult with her immunologist, EPIPEN 15 min later. Near complete resolution now only 1 or 2 small hives. Remote history (17 yrs ago) of difficult pregnancy, angioedema, one idiopathic urticaria, XOLAIR Rx x2 years and has been in remission since.
Redness, swelling, tender, lump hot to touch.  Cramping in stomach.
Information has been received from a physician, concerning a 15 year old female patient, who on 22-MAR-2007 was vaccinated with the first dose of Gardasil. Concomitant vaccine administration included DTaP (manufacturer unspecified) and a third vaccine [therapy unspecified]. On approximately 22-MAR-2007 the patient experienced dizziness. At the time of this report, the patient's dizziness persisted. The patient sought unspecified medical attention. Additional information has been requested.